The Covid-19 vaccine race: Where do we stand now? – The Irish Times

The northern hemisphere faces a bleak winter of rising Covid-19 cases, but signals that two rapidly engineered vaccines by Pfizer and Moderna work on 95 per cent of candidates on whom they have been tested have prompted joy.
The results are interim ones but they are, nevertheless, figures from large-scale Phase 3 clinical trials. The first 40 million doses could be administered in the United States by the year end.

Click here to view the original article.